{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:53:23Z","timestamp":1789433603408,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","award":["ED431G\/2023\/02"],"award-info":[{"award-number":["ED431G\/2023\/02"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008425","name":"Conseller\u00eda de Cultura, Educaci\u00f3n e Ordenaci\u00f3n Universitaria, Xunta de Galicia","doi-asserted-by":"publisher","award":["ED431C 2021\/17"],"award-info":[{"award-number":["ED431C 2021\/17"]}],"id":[{"id":"10.13039\/501100008425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008425","name":"Conseller\u00eda de Cultura, Educaci\u00f3n e Ordenaci\u00f3n Universitaria, Xunta de Galicia","doi-asserted-by":"publisher","award":["IN606B-2022\/009"],"award-info":[{"award-number":["IN606B-2022\/009"]}],"id":[{"id":"10.13039\/501100008425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","award":["RSU.UDC.MS05"],"award-info":[{"award-number":["RSU.UDC.MS05"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD23\/00057"],"award-info":[{"award-number":["CD23\/00057"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/01212"],"award-info":[{"award-number":["PI20\/01212"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015068","name":"Universidade de Santiago de Compostela","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015068","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s13346-026-02083-z","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T17:29:07Z","timestamp":1774891747000},"page":"2474-2487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nanoemulsion-based colistin for pulmonary delivery: Enhanced antibacterial efficacy against Acinetobacter baumannii"],"prefix":"10.1007","volume":"16","author":[{"given":"Marta","family":"Mart\u00ednez-Guiti\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Sanjurjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"V\u00e1zquez-Ucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Muras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Beceiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Crecente-Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"2083_CR1","doi-asserted-by":"crossref","unstructured":"Ramirez MS, Bonomo RA, Tolmasky ME. Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace. Biomolecules. 6 de mayo de 2020;10(5):720.","DOI":"10.3390\/biom10050720"},{"key":"2083_CR2","doi-asserted-by":"crossref","unstructured":"Suetens C, Latour K, K\u00e4rki T, Ricchizzi E, Kinross P, Moro ML, et\u00a0al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. noviembre de 2018;23(46):1800516.","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800516"},{"key":"2083_CR3","doi-asserted-by":"crossref","unstructured":"Fishbain J, Peleg AY. Treatment of Acinetobacter infections. Clin Infect Dis Off Publ Infect Dis Soc Am. 1 de julio de 2010;51(1):79\u201384.","DOI":"10.1086\/653120"},{"key":"2083_CR4","doi-asserted-by":"crossref","unstructured":"Pogue JM, Zhou Y, Kanakamedala H, Cai B. Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019. BMC Infect Dis. 6 de enero de 2022;22(1):36.","DOI":"10.1186\/s12879-021-07024-4"},{"issue":"3","key":"2083_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis marzo de. 2018;18(3):318\u201327.","journal-title":"Lancet Infect Dis marzo de"},{"key":"2083_CR6","doi-asserted-by":"crossref","unstructured":"El-Sayed Ahmed MAEG, Zhong LL, Shen C, Yang Y, Doi Y, Tian GB. Colistin and its role in the Era of antibiotic resistance: an extended review (2000\u20132019). Emerg Microbes Infect. diciembre de 2020;9(1):868\u201385.","DOI":"10.1080\/22221751.2020.1754133"},{"key":"2083_CR7","doi-asserted-by":"crossref","unstructured":"Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis Off Publ Infect Dis Soc Am. mayo de 2005;40(9):1333\u201341.","DOI":"10.1086\/429323"},{"issue":"12","key":"2083_CR8","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s40262-017-0561-1","volume":"56","author":"N Gr\u00e9goire","year":"2017","unstructured":"Gr\u00e9goire N, Aranzana-Climent V, Magr\u00e9ault S, Marchand S, Couet W. Clinical Pharmacokinetics and Pharmacodynamics of Colistin. Clin Pharmacokinet diciembre de. 2017;56(12):1441\u201360.","journal-title":"Clin Pharmacokinet diciembre de"},{"key":"2083_CR9","doi-asserted-by":"crossref","unstructured":"Nation RL, Velkov T, Li J. Colistin and polymyxin B: peas in a pod, or chalk and cheese? Clin Infect Dis Off Publ Infect Dis Soc Am. 1 de julio de 2014;59(1):88\u201394.","DOI":"10.1093\/cid\/ciu213"},{"issue":"1","key":"2083_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-015-0072-9","volume":"3","author":"M Gurjar","year":"2015","unstructured":"Gurjar M. Colistin for lung infection: an update. J Intensive Care. 2015;3(1):3.","journal-title":"J Intensive Care"},{"issue":"1","key":"2083_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1039\/D3PM00014A","volume":"1","author":"M Varache","year":"2024","unstructured":"Varache M, Rizzo S, Sayers EJ, Newbury L, Mason A, Liao CT, et al. Dextrin conjugation to colistin inhibits its toxicity, cellular uptake and acute kidney injury In vivo. RSC Pharm abril de. 2024;1(1):68\u201379.","journal-title":"RSC Pharm abril de"},{"issue":"7","key":"2083_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00228-015-1865-4","volume":"71","author":"A Ordooei Javan","year":"2015","unstructured":"Ordooei Javan A, Shokouhi S, Sahraei Z. A review on colistin nephrotoxicity. Eur J Clin Pharmacol julio de. 2015;71(7):801\u201310.","journal-title":"Eur J Clin Pharmacol julio de"},{"issue":"6","key":"2083_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02690-16","volume":"61","author":"MU Ahmed","year":"2017","unstructured":"Ahmed MU, Velkov T, Lin Y, Yun B, Nowell CJ, Zhou F, et al. Potential toxicity of polymyxins in human lung epithelial cells. Antimicrob Agents Chemother. 2017;61(6):1\u201312.","journal-title":"Antimicrob Agents Chemother"},{"issue":"163","key":"2083_CR14","first-page":"112966","volume":"2022","author":"C Dai","year":"2021","unstructured":"Dai C, Li M, Sun T, Zhang Y, Wang Y, Shen Z, et al. Colistin-induced pulmonary toxicity involves the activation of NOX4\/TGF-\u03b2\/mtROS pathway and the inhibition of Akt\/mTOR pathway. Food Chem Toxicol. August 2021;2022(163):112966.","journal-title":"Food Chem Toxicol"},{"key":"2083_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.addr.2014.11.004","volume":"85","author":"T Velkov","year":"2015","unstructured":"Velkov T, Abdul Rahim N, Zhou QT, Chan HK, Li J. Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead. Adv Drug Deliv Rev mayo de. 2015;85:65\u201382.","journal-title":"Adv Drug Deliv Rev mayo de"},{"issue":"3","key":"2083_CR16","first-page":"e02025","volume":"61","author":"YW Lin","year":"2017","unstructured":"Lin YW, Zhou QT, Cheah SE, Zhao J, Chen K, Wang J, et al. Pharmacokinetics\/Pharmacodynamics of pulmonary delivery of Colistin against Pseudomonas aeruginosa in a mouse lung infection model. Antimicrob Agents Chemother marzo de. 2017;61(3):e02025-e2116.","journal-title":"Antimicrob Agents Chemother marzo de"},{"issue":"6","key":"2083_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijantimicag.2014.02.009","volume":"43","author":"N Abed","year":"2014","unstructured":"Abed N, Couvreur P. Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. Int J Antimicrob Agents junio de. 2014;43(6):485\u201396.","journal-title":"Int J Antimicrob Agents junio de"},{"key":"2083_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2019.00872","volume":"7","author":"DY Wang","year":"2019","unstructured":"Wang DY, van der Mei HC, Ren Y, Busscher HJ, Shi L. Lipid-based antimicrobial delivery-systems for the treatment of bacterial infections. Front Chem. 2019;7:872.","journal-title":"Front Chem"},{"key":"2083_CR19","doi-asserted-by":"crossref","unstructured":"Preeti Null, Sambhakar S, Malik R, Bhatia S, Al Harrasi A, Rani C, et al. Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs. Scientifica. 2023;2023:6640103.","DOI":"10.1155\/2023\/6640103"},{"key":"2083_CR20","doi-asserted-by":"publisher","first-page":"122739","DOI":"10.1016\/j.ijpharm.2023.122739","volume":"635","author":"C Vairo","year":"2023","unstructured":"Vairo C, Villar Vidal M, Maria Hernandez R, Igartua M, Villullas S. Colistin- and amikacin-loaded lipid-based drug delivery systems for resistant gram-negative lung and wound bacterial infections. Int J Pharm marzo de. 2023;635:122739.","journal-title":"Int J Pharm marzo de"},{"key":"2083_CR21","doi-asserted-by":"publisher","first-page":"102259","DOI":"10.1016\/j.nano.2020.102259","volume":"29","author":"C Vairo","year":"2020","unstructured":"Vairo C, Basas J, Pastor M, Palau M, Gomis X, Almirante B, et al. in vitro and In vivo antimicrobial activity of sodium colistimethate and amikacin-loaded nanostructured lipid carriers (NLC). Nanomed Nanotechnol Biol Med octubre de. 2020;29:102259.","journal-title":"Nanomed Nanotechnol Biol Med octubre de"},{"key":"2083_CR22","doi-asserted-by":"crossref","unstructured":"Calvo P, Vila-Jato JL, Alonso MJ. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. J Pharm Sci. 1996;85(5).","DOI":"10.1021\/js950474+"},{"key":"2083_CR23","doi-asserted-by":"crossref","unstructured":"Garcia-Fuentes M, Prego C, Torres D, Alonso MJ. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery. Eur J Pharm Sci Off J Eur Fed Pharm Sci. mayo de 2005;25(1):133\u201343.","DOI":"10.1016\/j.ejps.2005.02.008"},{"issue":"2","key":"2083_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s13346-021-00920-x","volume":"11","author":"I Santalices","year":"2021","unstructured":"Santalices I, V\u00e1zquez-V\u00e1zquez C, Santander-Ortega MJ, Lozano V, Ara\u00fajo F, Sarmento B, et al. A nanoemulsion\/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin. Drug Deliv Transl Res abril de. 2021;11(2):524\u201345.","journal-title":"Drug Deliv Transl Res abril de"},{"key":"2083_CR25","doi-asserted-by":"crossref","unstructured":"Abellan-Pose R, Teijeiro-Vali\u00f1o C, Santander-Ortega MJ, Borrajo E, Vidal A, Garcia-Fuentes M, et\u00a0al. Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size. Int J Pharm. 25 de julio de 2016;509(1\u20132):107\u201317.","DOI":"10.1016\/j.ijpharm.2016.05.034"},{"key":"2083_CR26","unstructured":"Campeau S, Abmm D. 32nd Edition Performance Standards for Antimicrobial Susceptibility Testing [Internet]. 2022. Disponible en: https:\/\/clsi.org\/shop\/standards\/m100\/"},{"key":"2083_CR27","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Guiti\u00e1n M, V\u00e1zquez-Ucha JC, \u00c1lvarez-Fraga L, Conde-P\u00e9rez K, Bou G, Poza M, et\u00a0al. Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by peptide-PNA conjugates and synergy with colistin. J Antimicrob Chemother. 1 de enero de 2020;75(1):51\u20139.","DOI":"10.1093\/jac\/dkz409"},{"key":"2083_CR28","doi-asserted-by":"crossref","unstructured":"Mayer C, Muras A, Parga A, Romero M, Rumbo-Feal S, Poza M, et\u00a0al. Quorum sensing as a target for controlling surface associated motility and biofilm formation in 17978 TM. 2020;11(September):1\u201313.","DOI":"10.3389\/fmicb.2020.565548"},{"key":"2083_CR29","doi-asserted-by":"crossref","unstructured":"Muras A, Parga A, Mayer C, Otero A. Use of Quorum sensing inhibition strategies to control microfouling. Mar Drugs. 30 de enero de 2021;19(2):74.","DOI":"10.3390\/md19020074"},{"issue":"8","key":"2083_CR30","doi-asserted-by":"publisher","first-page":"e0182084","DOI":"10.1371\/journal.pone.0182084","volume":"12","author":"L \u00c1lvarez-Fraga","year":"2017","unstructured":"\u00c1lvarez-Fraga L, Rumbo-Feal S, P\u00e9rez A, G\u00f3mez MJ, Gayoso C, Vallejo JA, et al. Global assessment of small RNAs reveals a non-coding transcript involved in biofilm formation and attachment in Acinetobacter baumannii ATCC 17978. PLoS One. 2017;12(8):e0182084.","journal-title":"PLoS One"},{"key":"2083_CR31","doi-asserted-by":"crossref","unstructured":"Gethers M, Chen I, Abdelraouf K, Nicolau DP. In vivo efficacy of WCK 6777 (ertapenem\/zidebactam) against carbapenemase-producing Klebsiella pneumoniae in the neutropenic murine pneumonia model. J Antimicrob Chemother. 29 de junio de 2022;77(7):1931\u20137.","DOI":"10.1093\/jac\/dkac110"},{"issue":"6","key":"2083_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ijantimicag.2013.07.009","volume":"42","author":"J He","year":"2013","unstructured":"He J, Abdelraouf K, Ledesma KR, Chow DSL, Tam VH. Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model. Int J Antimicrob Agents diciembre de. 2013;42(6):559\u201364.","journal-title":"Int J Antimicrob Agents diciembre de"},{"issue":"10","key":"2083_CR33","first-page":"e01092","volume":"63","author":"JC V\u00e1zquez-Ucha","year":"2019","unstructured":"V\u00e1zquez-Ucha JC, Mart\u00ednez-Guiti\u00e1n M, Maneiro M, Conde-P\u00e9rez K, \u00c1lvarez-Fraga L, Torrens G, et al. Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother octubre de. 2019;63(10):e01092-e1119.","journal-title":"Antimicrob Agents Chemother octubre de"},{"issue":"4","key":"2083_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/jac\/45.4.493","volume":"45","author":"MJ Rodr\u00edguez-Hern\u00e1ndez","year":"2000","unstructured":"Rodr\u00edguez-Hern\u00e1ndez MJ, Pach\u00f3n J, Pichardo C, Cuberos L, Ib\u00e1\u00f1ez-Mart\u00ednez J, Garc\u00eda-Curiel A, et al. Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia. J Antimicrob Chemother abril de. 2000;45(4):493\u2013501.","journal-title":"J Antimicrob Chemother abril de"},{"issue":"3","key":"2083_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1517\/17425247.2012.660480","volume":"9","author":"SA Antoniu","year":"2012","unstructured":"Antoniu SA, Cojocaru I. Inhaled colistin for lower respiratory tract infections. Expert Opin Drug Deliv. 2012;9(3):333\u201342.","journal-title":"Expert Opin Drug Deliv"},{"key":"2083_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jgar.2020.08.021","volume":"24","author":"J Liu","year":"2021","unstructured":"Liu J, Shu Y, Zhu F, Feng B, Zhang Z, Liu L, et al. Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a systematic review and network meta-analysis. J Glob Antimicrob Resist. 2021;24:136\u201347.","journal-title":"J Glob Antimicrob Resist"},{"key":"2083_CR37","doi-asserted-by":"crossref","unstructured":"Moreno-Sastre M, Pastor M, Esquisabel A, Sans E, Vi\u00f1as M, Fleischer A, et al. Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis. Int J Pharm. 10 Feb 2016;498(1\u20132):263\u201373.","DOI":"10.1016\/j.ijpharm.2015.12.028"},{"key":"2083_CR38","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2147\/IJN.S198353","volume":"14","author":"A Mukherjee","year":"2019","unstructured":"Mukherjee A, Waters AK, Kalyan P, Achrol AS, Kesari S, Yenugonda VM. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomedicine. 2019;14:1937\u201352.","journal-title":"Int J Nanomedicine"},{"issue":"9","key":"2083_CR39","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1002\/jps.23203","volume":"101","author":"SJ Wallace","year":"2012","unstructured":"Wallace SJ, Li J, Nation RL, Prankerd RJ, Boyd BJ. Interaction of colistin and colistin methanesulfonate with liposomes: colloidal aspects and implications for formulation. J Pharm Sci septiembre de. 2012;101(9):3347\u201359.","journal-title":"J Pharm Sci septiembre de"},{"issue":"5","key":"2083_CR40","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/jac\/dkg443","volume":"52","author":"HP Stallmann","year":"2003","unstructured":"Stallmann HP, Faber C, Slotema ET, Lyaruu DM, Bronckers ALJJ, Amerongen AVN, et al. Continuous-release or burst-release of the antimicrobial peptide human lactoferrin 1\u201311 (hLF1-11) from calcium phosphate bone substitutes. J Antimicrob Chemother noviembre de. 2003;52(5):853\u20135.","journal-title":"J Antimicrob Chemother noviembre de"},{"issue":"1","key":"2083_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/jac\/dkq422","volume":"66","author":"RL Soon","year":"2011","unstructured":"Soon RL, Nation RL, Cockram S, Moffatt JH, Harper M, Adler B, et al. Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment. J Antimicrob Chemother enero de. 2011;66(1):126\u201333.","journal-title":"J Antimicrob Chemother enero de"},{"key":"2083_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102259","volume":"29","author":"C Vairo","year":"2020","unstructured":"Vairo C, Basas J, Pastor M, Palau M, Gomis X, Almirante B, et al. in vitro and In vivo antimicrobial activity of sodium colistimethate and amikacin-loaded nanostructured lipid carriers (NLC). Nanomedicine Nanotechnol Biol Med. 2020;29:102259.","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"key":"2083_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.actbio.2018.10.013","volume":"82","author":"YH Liu","year":"2018","unstructured":"Liu YH, Kuo SC, Yao BY, Fang ZS, Lee YT, Chang YC, et al. Colistin nanoparticle assembly by coacervate complexation with polyanionic peptides for treating drug-resistant gram-negative bacteria. Acta Biomater. 2018;82:133\u201342.","journal-title":"Acta Biomater"},{"key":"2083_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10010057","author":"S Scutera","year":"2021","unstructured":"Scutera S, Argenziano M, Sparti R, Bessone F, Bianco G, Bastiancich C, et al. Enhanced antimicrobial and antibiofilm effect of new colistin-loaded human albumin nanoparticles. Antibiotics. 2021. https:\/\/doi.org\/10.3390\/antibiotics10010057.","journal-title":"Antibiotics"},{"key":"2083_CR45","doi-asserted-by":"publisher","first-page":"1492543","DOI":"10.3389\/fvets.2024.1492543","volume":"11","author":"J Zhang","year":"2024","unstructured":"Zhang J, Wang X, Li P, Gao Y, Wang R, Li S, et al. Colistin-niclosamide-loaded nanoemulsions and nanoemulsion gels for effective therapy of colistin-resistant Salmonella infections. Front Vet Sci. 2024;11:1492543.","journal-title":"Front Vet Sci"},{"issue":"6","key":"2083_CR46","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ijantimicag.2010.01.015","volume":"35","author":"D Nicolosi","year":"2010","unstructured":"Nicolosi D, Scalia M, Nicolosi VM, Pignatello R. Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria. Int J Antimicrob Agents. 2010;35(6):553\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"2083_CR47","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/21691401.2017.1307209","volume":"46","author":"P Pushparaj Selvadoss","year":"2018","unstructured":"Pushparaj Selvadoss P, Nellore J, Balaraman Ravindrran M, Sekar U, Tippabathani J. Enhancement of antimicrobial activity by liposomal oleic acid-loaded antibiotics for the treatment of multidrug-resistant Pseudomonas aeruginosa. Artif Cells Nanomedicine Biotechnol. 2018;46(2):268\u201373.","journal-title":"Artif Cells Nanomedicine Biotechnol"},{"key":"2083_CR48","doi-asserted-by":"publisher","first-page":"e65836","DOI":"10.7554\/eLife.65836","volume":"10","author":"A Sabnis","year":"2021","unstructured":"Sabnis A, Hagart KL, Kl\u00f6ckner A, Becce M, Evans LE, Furniss RCD, et al. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. Elife. 2021;10:e65836.","journal-title":"Elife"},{"issue":"5418","key":"2083_CR49","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","volume":"284","author":"JW Costerton","year":"1999","unstructured":"Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318\u201322.","journal-title":"Science"},{"key":"2083_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00148","volume":"3","author":"I Roca","year":"2012","unstructured":"Roca I, Espinal P, Vila-Farr\u00e9s X, Vila J. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol. 2012;3:148.","journal-title":"Front Microbiol"},{"key":"2083_CR51","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.ijbiomac.2022.07.176","volume":"217","author":"V Kaushik","year":"2022","unstructured":"Kaushik V, Tiwari M, Tiwari V. Interaction of RecA mediated SOS response with bacterial persistence, biofilm formation, and host response. Int J Biol Macromol. 2022;217:931\u201343.","journal-title":"Int J Biol Macromol"},{"key":"2083_CR52","doi-asserted-by":"crossref","unstructured":"Shenkutie AM, Zhang J, Yao M, Asrat D, Chow FWN, Leung PHM. Effects of Sub-Minimum Inhibitory Concentrations of Imipenem and Colistin on Expression of Biofilm-Specific Antibiotic Resistance and Virulence Genes in Acinetobacter baumannii Sequence Type 1894. 2022;","DOI":"10.3390\/ijms232012705"},{"issue":"5","key":"2083_CR53","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jcf.2015.12.005","volume":"15","author":"E Sans-Serramitjana","year":"2016","unstructured":"Sans-Serramitjana E, Fust\u00e9 E, Mart\u00ednez-Garriga B, Merlos A, Pastor M, Pedraz JL, et al. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients. J Cyst Fibros. 2016;15(5):611\u20138.","journal-title":"J Cyst Fibros"},{"key":"2083_CR54","doi-asserted-by":"publisher","first-page":"111751","DOI":"10.1016\/j.jinorgbio.2022.111751","volume":"230","author":"M Iafisco","year":"2022","unstructured":"Iafisco M, Carella F, Degli Esposti L, Adamiano A, Catalucci D, Modica J, et al. Biocompatible antimicrobial colistin loaded calcium phosphate nanoparticles for the counteraction of biofilm formation in cystic fibrosis related infections. J Inorg Biochem. 2022;230:111751.","journal-title":"J Inorg Biochem"},{"issue":"1","key":"2083_CR55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2958.2008.06152.x","volume":"68","author":"SJ Pamp","year":"2008","unstructured":"Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol. 2008;68(1):223\u201340.","journal-title":"Mol Microbiol"},{"issue":"13\u201314","key":"2083_CR56","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","volume":"65","author":"RY Pelgrift","year":"2013","unstructured":"Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013;65(13\u201314):1803\u201315.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2083_CR57","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0030-5898(20)31101-9","volume":"15","author":"AG Gristina","year":"1984","unstructured":"Gristina AG, Costerton JW. Bacterial adherence and the glycocalyx and their role in musculoskeletal infection. Orthop Clin North Am julio de. 1984;15(3):517\u201335.","journal-title":"Orthop Clin North Am julio de"},{"issue":"9","key":"2083_CR58","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1023\/A:1013073508318","volume":"18","author":"V Sihorkar","year":"2001","unstructured":"Sihorkar V, Vyas SP. Biofilm consortia on biomedical and biological surfaces: delivery and targeting strategies. Pharm Res. 2001;18(9):1247\u201354.","journal-title":"Pharm Res"},{"issue":"12","key":"2083_CR59","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.tim.2023.06.007","volume":"31","author":"A Maure","year":"2023","unstructured":"Maure A, Robino E, Van der Henst C. The intracellular life of Acinetobacter baumannii. Trends Microbiol. 2023;31(12):1238\u201350.","journal-title":"Trends Microbiol"},{"key":"2083_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040019","author":"H Qiu","year":"2012","unstructured":"Qiu H, Kuolee R, Harris G, Van Rooijen N, Patel GB, Chen W. Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection. PLoS One. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0040019.","journal-title":"PLoS One"},{"issue":"1","key":"2083_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53846-3","volume":"9","author":"Y Sato","year":"2019","unstructured":"Sato Y, Unno Y, Miyazaki C, Ubagai T, Ono Y. Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages. Sci Rep. 2019;9(1):17462.","journal-title":"Sci Rep"},{"issue":"6","key":"2083_CR62","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijantimicag.2014.02.009","volume":"43","author":"N Abed","year":"2014","unstructured":"Abed N, Couvreur P. Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. Int J Antimicrob Agents. 2014;43(6):485\u201396.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"2083_CR63","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1007\/s13346-022-01287-3","volume":"13","author":"S Maghrebi","year":"2023","unstructured":"Maghrebi S, Thomas N, Prestidge CA, Joyce P. Inulin-lipid hybrid (ILH) microparticles promote pH-triggered release of rifampicin within infected macrophages. Drug Deliv Transl Res. 2023;13(6):1716\u201329.","journal-title":"Drug Deliv Transl Res"},{"issue":"7","key":"2083_CR64","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1021\/acsami.9b22991","volume":"12","author":"S Maghrebi","year":"2020","unstructured":"Maghrebi S, Joyce P, Jambhrunkar M, Thomas N, Prestidge CA. Poly(lactic-co-glycolic) Acid-Lipid Hybrid Microparticles Enhance the Intracellular uptake and antibacterial activity of rifampicin. ACS Appl Mater Interfaces febrero de. 2020;12(7):8030\u20139.","journal-title":"ACS Appl Mater Interfaces febrero de"},{"issue":"12","key":"2083_CR65","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.tim.2023.06.007","volume":"31","author":"A Maure","year":"2023","unstructured":"Maure A, Robino E, Van der Henst C. The intracellular life of Acinetobacter baumannii. Trends Microbiol diciembre de. 2023;31(12):1238\u201350.","journal-title":"Trends Microbiol diciembre de"},{"key":"2083_CR66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.addr.2014.11.004","volume":"85","author":"T Velkov","year":"2015","unstructured":"Velkov T, Abdul Rahim N, Zhou QT, Chan HK, Li J. Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead. Adv Drug Deliv Rev. 2015;85:65\u201382.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2083_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2014.02.005","volume":"87","author":"S Doktorovova","year":"2014","unstructured":"Doktorovova S, Souto EB, Silva AM. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data. Eur J Pharm Biopharm. 2014;87(1):1\u201318.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"2083_CR68","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijpharm.2014.10.048","volume":"477","author":"M Pastor","year":"2014","unstructured":"Pastor M, Moreno-Sastre M, Esquisabel A, Sans E, Vi\u00f1as M, Bachiller D, et al. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis. Int J Pharm. 2014;477(1\u20132):485\u201394.","journal-title":"Int J Pharm"},{"key":"2083_CR69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.nano.2019.02.014","volume":"18","author":"M Pastor","year":"2019","unstructured":"Pastor M, Basas J, Vairo C, Gainza G, Moreno-Sastre M, Gomis X, et al. Safety and effectiveness of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and In vivo studies following pulmonary and intramuscular administration. Nanomedicine Nanotechnol Biol Med. 2019;18:101\u201311.","journal-title":"Nanomedicine Nanotechnol Biol Med"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02083-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02083-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02083-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:04:25Z","timestamp":1782309865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02083-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2083"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02083-z","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors approved participation and the publication of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study was approved by the Ethics and Clinical Research Committee (CHUAC, project code P169\/15002\/2023\/005; Spain).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Nothing to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}